Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
Key Takeaways
- •Latest on Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials — reported by TechCrunch AI for the news space.
- •This story was reported by TechCrunch AI, covering developments in the news space.
- •AI advancements continue to reshape industries — read the full article on TechCrunch AI for complete coverage.
📖 Continue reading the full article:
Read Full Article on TechCrunch AI →


